10 research outputs found
Comparison of hazard ratios (HR) with 95% confidence intervals (CI) for all-cause, cardiovascular and coronary mortality among non-diabetic women with history of CVD and diabetic women without CVD (N = 942).
*<p>p<0.05 for comparison with the no diabetes with CVD group.</p><p>Women with no diabetes and history of CVD were used as the reference group.</p>a<p>Late onset diabetes defined as having diabetes since 10 years or less.</p>b<p>Long-term diabetes defined as having diabetes since more than 10 years.</p>c<p>Adjusted for age, smoking status, physical activity, systolic blood pressure, body mass index and education.</p><p>Abbreviations: CVD, cardiovascular disease.</p
Survival curves according to the presence of diabetes or history of cardiovascular disease (CVD).
<p>a: Total mortality. b: Cardiovascular disease mortality. c: Coronary heart disease (CHD) mortality.</p
Characteristics of older women by presence or absence of diabetes and cardiovascular disease (CVD<sup>a</sup>) (N = 9218).
<p>Values are mean ± standard deviation (SD) or percentages.</p>*<p>p<0.05,</p>**<p>p<0.005 for pairwise comparison with no diabetes and no CVD category.</p><p>p values were based on t-tests and chi-square tests for trend for multilevel categorical variables.</p>a<p>CVD was defined as myocardial infarction or stroke.</p>b<p>Former smoking was defined as at least 100 cigarettes for the all life. Chi-square tests for trend.</p>c<p>Physical activity expressed as median [25%–75%] and Mann-Whitney rank sum test performed.</p
Incidence and hazard ratios (HR) with 95% confidence intervals (CI) for all-cause, cardiovascular and coronary mortality (N = 9218).
<p>Women with no diabetes and no history of CVD were used as the reference group.</p>*<p>p<0.001 for comparison with the no diabetes and no CVD group. p values were based on log-rank tests for the rates of death and Wald test from the Cox model for other variables.</p>a<p>Adjusted for age, smoking status, physical activity, systolic blood pressure, body mass index and education.</p><p>Abbreviations: CVD, cardiovascular disease.</p
Associations of additional predictor covariates with total health care costs for 1 year after SOF year 10 exam, adjusted only for base model covariates<sup>*</sup><sup>†</sup>.
<p>Associations of additional predictor covariates with total health care costs for 1 year after SOF year 10 exam, adjusted only for base model covariates<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0191642#t004fn001" target="_blank">*</a></sup><sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0191642#t004fn002" target="_blank">†</a></sup>.</p
Associations of weight change and BMI with total health care costs, outpatient costs, hospital stays, and SNF stays (base model without interaction terms)<sup>*</sup><sup>^</sup>.
<p>Associations of weight change and BMI with total health care costs, outpatient costs, hospital stays, and SNF stays (base model without interaction terms)<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0191642#t003fn001" target="_blank">*</a></sup><sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0191642#t003fn002" target="_blank">^</a></sup>.</p
Distribution of study population characteristics at SOF year 10 exam.
<p>Distribution of study population characteristics at SOF year 10 exam.</p
Characteristics of 4605 women and according to enrollment and BMI status<sup>*</sup>.
<p>Characteristics of 4605 women and according to enrollment and BMI status<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0191642#t002fn001" target="_blank">*</a></sup>.</p
Characteristics of MrOS participants with PSG sleep staging and <i>APOE</i> genotyping.
<p>Characteristics of MrOS participants with PSG sleep staging and <i>APOE</i> genotyping.</p